Choreo, LLC Gsk PLC Transaction History

Choreo, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jun 04, 2020	SELL	$37.8 - $42.69 $218,181 - $246,406	-5,772 Closed	0 $0
Q3 2018 Jun 04, 2020	BUY	$39.75 - $42.69 $20,550 - $22,070	517 Added 9.84%	5,772 $235,000
Q2 2018 Jun 04, 2020	BUY	$39.61 - $42.76 $208,150 - $224,703	5,255 New	5,255 $214,000
Q4 2017 Jun 04, 2020	SELL	$35.34 - $41.9 $227,660 - $269,919	-6,442 Closed	0 $0
Q3 2017 Jun 04, 2020	BUY	$39.44 - $41.55 $46,696 - $49,195	1,184 Added 22.52%	6,442 $265,000
Q2 2017 Jun 04, 2020	SELL	N/A	-21 Reduced 0.4%	5,258 $229,000
Q1 2017 Jun 04, 2020	SELL	N/A	-174 Reduced 3.19%	5,279 $226,000
Q4 2016 Jun 04, 2020	BUY	N/A	212 Added 4.05%	5,453 $212,000
Q3 2016 Jun 04, 2020	BUY	N/A	5,241	5,241 $228,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

Stay updated on Choreo, LLC with notifications on news.